Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

96 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A randomized, blinded, parallel-group, pilot trial of mycophenolate mofetil (CellCept) compared with interferon beta-1a (Avonex) in patients with relapsing-remitting multiple sclerosis.
Frohman EM, Cutter G, Remington G, Gao H, Rossman H, Weinstock-Guttman B, Durfee JE, Conger A, Carl E, Treadaway K, Lindzen E, Salter A, Frohman TC, Shah A, Bates A, Cox JL, Dwyer MG, Stüve O, Greenberg BM, Racke MK, Zivadinov R. Frohman EM, et al. Among authors: frohman tc. Ther Adv Neurol Disord. 2010 Jan;3(1):15-28. doi: 10.1177/1756285609353354. Ther Adv Neurol Disord. 2010. PMID: 21180633 Free PMC article.
Symptomatic therapy in multiple sclerosis.
Frohman TC, Castro W, Shah A, Courtney A, Ortstadt J, Davis SL, Logan D, Abraham T, Abraham J, Remington G, Treadaway K, Graves D, Hart J, Stuve O, Lemack G, Greenberg B, Frohman EM. Frohman TC, et al. Among authors: frohman em. Ther Adv Neurol Disord. 2011 Mar;4(2):83-98. doi: 10.1177/1756285611400658. Ther Adv Neurol Disord. 2011. PMID: 21694806 Free PMC article.
Current and emerging therapies in multiple sclerosis: a systematic review.
Castro-Borrero W, Graves D, Frohman TC, Flores AB, Hardeman P, Logan D, Orchard M, Greenberg B, Frohman EM. Castro-Borrero W, et al. Among authors: frohman em, frohman tc. Ther Adv Neurol Disord. 2012 Jul;5(4):205-20. doi: 10.1177/1756285612450936. Ther Adv Neurol Disord. 2012. PMID: 22783370 Free PMC article.
Neurotherapeutic Strategies for Multiple Sclerosis.
Frohman TC, Beh SC, Kildebeck EJ, Narayan R, Treadaway K, Frohman EM. Frohman TC, et al. Among authors: frohman em. Neurol Clin. 2016 Aug;34(3):483-523. doi: 10.1016/j.ncl.2016.05.001. Neurol Clin. 2016. PMID: 27445239 Review.
A new measure of dysconjugacy in INO: the first-pass amplitude.
Frohman EM, O'Suilleabhain P, Dewey RB Jr, Frohman TC, Kramer PD. Frohman EM, et al. Among authors: frohman tc. J Neurol Sci. 2003 Jun 15;210(1-2):65-71. doi: 10.1016/s0022-510x(03)00027-3. J Neurol Sci. 2003. PMID: 12736091
The neuro-ophthalmology of multiple sclerosis.
Frohman EM, Frohman TC, Zee DS, McColl R, Galetta S. Frohman EM, et al. Among authors: frohman tc. Lancet Neurol. 2005 Feb;4(2):111-21. doi: 10.1016/S1474-4422(05)00992-0. Lancet Neurol. 2005. PMID: 15664543 Review.
96 results